COMPARISON OF PREDNISOLONE, VINCRISTINE, METHOTREXATE AND 6-MERCAPTOPURINE (POMP) VS VINCRISTINE AND PREDNISONE (V-P) INDUCTION IN CHILDHOOD ACUTE-LEUKEMIA

被引：0
|
作者：
BERRY, D [1 ]
PULLEN, J [1 ]
VIETTI, T [1 ]
SULLIVAN, M [1 ]
FERNBACH, D [1 ]
机构：
[1] SW ONCOL GRP,3500 RAINBOW BLVD,KANSAS CITY,KS 66103
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1974年 / 15卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：33 / 33
页数：1
相关论文
共 50 条
  • [21] HIGH-DOSE, CONTINUOUS-INFUSION CYCLOPHOSPHAMIDE, CYTARABINE, VINCRISTINE, AND PREDNISONE FOR REMISSION INDUCTION IN REFRACTORY ADULT ACUTE-LEUKEMIA
    GUTHRIE, TH
    CANCER, 1987, 59 (07) : 1255 - 1257
  • [22] 200 mg/m2 melphalan and autograft followed by maintenance chemotherapy with 6-mercaptopurine (6MP), methotrexate (MTX), and vincristine-prednisone (VP) in 65 first remission acute lymphoblastic leukemia patients.
    Mehta, J
    Powles, R
    Sirohi, B
    Treleaven, J
    Kulkarni, S
    Singhal, S
    BLOOD, 2003, 102 (11) : 739A - 740A
  • [23] PHASE-I STUDY OF DOXORUBICIN, ONCOVIN, 6-MERCAPTOPURINE AND PREDNISONE (DOMP) IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
    HUMPHREY, GB
    NITSCHKE, R
    DANNAWI, H
    CLINICAL RESEARCH, 1975, 23 (03): : A340 - A340
  • [24] A Comparison of Two Induction Regimens for Older Patients with Acute Lymphoblastic Leukemia: Daunorubicin, Vincristine and Prednisone (DVP) is Worth Considering
    Landsburg, Daniel
    Porter, David
    Stadtmauer, Edward
    Loren, Alison
    Tsai, Donald
    Frey, Noelle
    Goldstein, Steven
    Hexner, Elizabeth
    Nasta, Sunita Dwivedy
    Perl, Alexander
    Davis, Jennifer
    Luger, Selina
    BLOOD, 2010, 116 (21) : 1334 - 1334
  • [25] PROGNOSTIC-SIGNIFICANCE OF METHOTREXATE AND 6-MERCAPTOPURINE DOSAGE DURING MAINTENANCE CHEMOTHERAPY FOR CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
    SCHMIEGELOW, K
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1991, 8 (04) : 301 - 312
  • [26] Randomized Trial to Compare LSA2L2-Type Maintenance Therapy to Daily 6-Mercaptopurine and Weekly Methotrexate With Vincristine and Dexamethasone Pulse for Children With Acute Lymphoblastic Leukemia
    Nagatoshi, Yoshihisa
    Matsuzaki, Akinobu
    Suminoe, Aiko
    Inada, Hiroko
    Ueda, Kouichiro
    Kawakami, Kiyoshi
    Yanai, Fumio
    Nakayama, Hideki
    Moritake, Hiroshi
    Itonaga, Nobuyoshi
    Hotta, Noriko
    Fujita, Kyoko
    Hidaka, Yasufumi
    Yamanaka, Takeharu
    Kawano, Yoshifumi
    Okamura, Jun
    PEDIATRIC BLOOD & CANCER, 2010, 55 (02) : 239 - 247
  • [27] The impact of high-dose methotrexate on intracellular 6-mercaptopurine disposition during interval therapy of childhood acute lymphoblastic leukemia
    de Beaumais, T. Adam
    Dervieux, T.
    Fakhoury, M.
    Medard, Y.
    Azougagh, S.
    Zhang, D.
    Yakouben, K.
    Jacqz-Aigrain, E.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (04) : 653 - 658
  • [28] The impact of high-dose methotrexate on intracellular 6-mercaptopurine disposition during interval therapy of childhood acute lymphoblastic leukemia
    T. Adam de Beaumais
    T. Dervieux
    M. Fakhoury
    Y. Medard
    S. Azougagh
    D. Zhang
    K. Yakouben
    E. Jacqz-Aigrain
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 653 - 658
  • [29] COMPARISON OF INTERMITTENT OR CONTINUOUS METHOTREXATE PLUS 6-MERCAPTOPURINE IN REGIMENS FOR STANDARD-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDHOOD (JCCLSG-S811)
    KOIZUMI, S
    FUJIMOTO, T
    TAKEDA, T
    YATABE, M
    UTSUMI, J
    MIMAYA, J
    NINOMIYA, T
    YANAI, M
    CANCER, 1988, 61 (07) : 1292 - 1300
  • [30] COMPARISON OF INTERMITTENT OR CONTINUOUS METHOTREXATE PLUS 6-MERCAPTOPURINE IN REGIMENS FOR STANDARD-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDHOOD (CCLSG-S811)
    KOIZUMI, S
    FUJIMOTO, T
    MEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (06): : 396 - 397
12345